EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Compliance to Competitive Advantage in Pharma Supply

    Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser

KNOWLEDGE BANK

  • Articles

    Data Security Challenges in Pharma IT: Safeguarding Sensitive Information

    The pharmaceutical industry faces several data security challenges in its IT infrastructure primarily related to safeguarding sensitive information The nature of the data regulatory requirements and the increasing sophistication of cyber threats

    Unlocking Value: Data Science Applications in Pharmacoeconomics

    In the realm of healthcare where every decision has significant financial implications pharmacoeconomics plays a pivotal role It involves the evaluation of the economic impact of pharmaceutical products and services

    Bispecific Antibodies: Transforming the Future of Oncology

    For two decades bispecific antibodies occupied an awkward position in pharmaceutical oncology strategy scientifically compelling commercially unproven and persistently difficult to manufacture That characterisation no longer holds Nineteen bispecific antibodies have been approved globally and combined sales of the class passed twelve billion dollars in with several products now anchoring

    Efficiency in Bioprocessing: Unveiling Upstream and Downstream Operations

    Bioprocessing plays a crucial role in the pharmaceutical biotechnology and healthcare industries ensuring the efficient production of biologics vaccines and other biobased products

    Emerging Technologies in Automation Machinery for the Pharmaceutical Industry

    Pharmaceutical industry has long been a forerunner on the use of technology where it has proved vital in increasing efficiency quality and safety Automation machinery has become more important over the years due to its ability to efficiently handle manufacturing packaging and distribution challenges Advanced technology is improving automation machinery as an integration tool in the pharmaceutical...

    mRNA and Oligonucleotide Therapeutics: Emerging Synergies in Genetic Medicine

    MRNA therapies work by introducing synthetic mRNA encoding a therapeutic protein enabling transient protein expression that can replace deficient enzymes stimulate immune responses or facilitate gene editing This additive approach is beneficial for diseases caused by lossoffunction mutations or when temporary protein expression is desired

TOP ARTICLES

press releases Read more...

Mission Bio Launches Tapestri® Triomics for Simultaneous DNA, RNA, and Protein Analysis at Single-Cell Resolution

Mission Bio a leader in singlecell multiomics today announced Tapestri Triomics a new expansion of the Tapestri Platform that simultaneously analyzes DNA RNA and protein in the same cell By connecting genotype

Phanes Therapeutics announces US patent granted to its proprietary bispecific antibody technology platform PACbody®

Phanes Therapeutics Inc Phanes a clinicalstage biotech company focused on innovative drug discovery and development in immunooncology IO announced today that the US Patent and Trademark Office

DifGen Pharmaceuticals LLC Announces U.S. FDA Approval of Epinephrine Injection USP, 1 mg/mL, Single-Dose Vials

DifGen Pharmaceuticals LLC DifGen a US based specialty generic pharmaceutical company today announced that the US Food and Drug Administration FDA approved its Abbreviated New Drug Application

GT Biopharma Announces Potential New Indication for GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager, for Multiple Myeloma

GT Biopharma Inc the Company NASDAQ GTBP a clinical stage immunooncology company focused on developing innovative therapeutics based on the Companys proprietary TriKE natural killer NK

15 - 17

Sep 2026

COPD Drug Development Summit 2026

Street, Boston, MA 02210, USA

21 - 23

Sep 2026

21 - 23

Sep 2026

Cancer R&D World Conference

Hilton Garden Inn Miami Dolphi...

22 - 23

Sep 2026

22 - 24

Sep 2026

28 - 01

Sep 2026

29 - 01

Sep 2026

10th IPF Summit 2026

Boston, MA, USA

29 - 01

Sep 2026

Powtech Technopharm 2026

Nuremberg, Germany

LATEST NEWS Read more...

Novo Nordisk and Anthropic collaborate to advance AI-led drug discovery

Novo Nordisk and Anthropic have announced a collaboration to accelerate drug discovery and development using artificial intelligence AI while also expanding AIsupported software development at Novo

Twist Bioscience joins Lilly TuneLab to support antibody drug discover

Twist Bioscience has entered into an agreement with Lilly TuneLab an artificial intelligence and machine learning AIML drug discovery platform developed by Eli Lilly and Company

Ori Biotech announces $120 million, ten-year partnership for automated cell therapy manufacturing

Ori Biotech Ori a cell and gene therapy manufacturing technology company has announced a tenyear strategic collaboration with a biopharmaceutical company to integrate its IRO platform into a commercial cell therapy manufacturing process

Mighty Therapeutics partners with POLG Foundation to develop preclinical model for mitochondrial disorders and Parkinson’s disease

Mighty Therapeutics a commercialstage biotechnology company developing medicines targeting mitochondrial dysfunction has started a research collaboration with The POLG Foundation Dr Carolyn Sue

Axiom Biosciences partners with GeneFab to expand manufacturing and clinical development capabilities

Axiom Biosciences a clinicalstage biotechnology company developing regenerative therapies and targeted biologics has entered into a strategic partnership with cell and gene therapy contract development and manufacturing organisation CDMO GeneFab

Asimov Partners with Sidewinder Therapeutics on Cell Line Development for Bispecific Antibody

Asimov has entered into a cell line development partnership with Sidewinder Therapeutics to support the development of a fourchain bispecific antibody candidate for solid tumour treatment